Full-Time

Validation Services Analyst

Posted on 3/25/2025

Clairo

Clairo

5,001-10,000 employees

Generates clinical evidence for trials

No salary listed

Junior, Mid

Bengaluru, Karnataka, India

Category
QA & Testing
Automation Testing
Quality Assurance
Required Skills
SQL
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Clairo referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Bachelor’s degree in computer science, engineering or related field, or suitable related job experience
  • 2+ years’ experience in software validation or quality assurance, preferably within the pharmaceutical industry and/or within supply chain
  • Proven ability to validate software applications using standardized methodologies
  • Proven ability to analyze complex issues
  • Working knowledge of SQL
  • Competency with MS Office
  • Working knowledge of test management tools
  • Working knowledge of automated testing tools
  • Working knowledge of Software Development Life Cycles
  • Ability to work in a team environment
  • Strong problem-solving and organizational skills
  • High attention to detail
  • Demonstrated ability to manage multiple tasks simultaneously and complete work within allocated time frames
  • Excellent oral and written communication skills
Responsibilities
  • Interfacing with client sponsors, business managers, application users, and shared services
  • Reviewing, understanding, and suggesting improvements to user requirements and functional specifications
  • Planning a validation approach for small applications or modules of larger applications
  • Working within a team to ensure high quality application releases
  • Building validation (test) scripts for single functions and scenarios in alignment with internal and/or client processes
  • Assisting in the creation of test script suites for modules and full applications, ensuring complete coverage of new code for application releases
  • Executing and documenting the results of validation scripts for application releases, including both new and regression scripts
  • Creating automated test scripts
  • Ensuring execution of automated test scripts as appropriate in support of application releases
  • Assisting in the troubleshooting of application failures
  • Verifying work of other validation services team members to ensure quality deliverables
  • Reading, understanding and adhering to organizational Standard Operating Procedures (SOPs)
  • Assisting in establishing and enforcing departmental standards
  • Participating in the modification of company SOPs
  • Understanding and adhering to client SOPs
  • Helping others to accomplish results
  • Performing other duties as assigned
  • Suggesting and implementing improvements to work processes to better meet project schedule and budget, reduce project risk, or improve the final product
  • Attending and participating in applicable company sponsored and client-required training
  • Self-directed learning of applicable tools, processes, and industry standards

Clario specializes in generating clinical evidence for medical research by combining scientific expertise with a wide range of endpoint technology. Their products support various types of clinical trials, including decentralized, hybrid, and site-based trials, allowing for flexibility in how studies are conducted. Clario stands out from competitors due to its extensive experience, having participated in nearly 19,000 clinical trials and achieved 870 regulatory approvals, which provides a high level of reliability in the data they produce. The company's goal is to empower partners in the healthcare industry to improve patient outcomes by providing comprehensive and trustworthy clinical evidence.

Company Size

5,001-10,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$29.9M

Headquarters

London, United Kingdom

Founded

1972

Simplify Jobs

Simplify's Take

What believers are saying

  • Clario's acquisition of NeuroRx enhances its neuroscience capabilities in multiple sclerosis imaging.
  • FDA clearance of SpiroSphere® with wireless ECG streamlines data collection in clinical trials.
  • Clario's $10 billion IPO filing indicates strong market interest and growth potential.

What critics are saying

  • Integration challenges may arise from Clario's acquisitions of NeuroRx and WCG's eCOA business.
  • AI partnership with PathAI could face algorithmic bias and data privacy concerns.
  • Wireless ECG device reliability and data security pose risks to trial outcomes and trust.

What makes Clairo unique

  • Clario offers a broad endpoint technology platform for diverse clinical trial models.
  • Trial Anywhere™ enables decentralized, hybrid, and site-based clinical trials with rich evidence.
  • Clario's 50 years of experience and 870 regulatory approvals enhance its credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Company News

Fierce Biotech
Mar 18th, 2025
Clario continues acquisition spree with imaging specialist NeuroRx

NeuroRx founder and CEO Douglas Arnold, M.D., is also joining Clario as a senior scientific advisor, Clario announced in a March 17 release.

PE Hub
Mar 17th, 2025
PE-backed Clario picks up medical research firm NeuroRx

Clario, a Philadelphia-based provider of endpoint data solutions to the clinical trial industry, has acquired NeuroRx, a Montreal-based provider of imaging analysis on multiple sclerosis.

CityBiz
Mar 17th, 2025
Clario Acquires NeuroRx for Imaging Expertise

Clario, a leader in endpoint data solutions for clinical trials, has acquired NeuroRx, an imaging analysis expert in multiple sclerosis. This acquisition enhances Clario's neuroscience capabilities. NeuroRx's founder, Douglas Arnold, M.D., will join Clario as Senior Scientific Advisor. Clario also plans to acquire WCG’s eCOA business, further strengthening its neuroscience expertise.

PR Newswire
Mar 10th, 2025
Clario Enters Into Definitive Agreement To Acquire Wcg'S Ecoa Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neurosciencePHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases

Clario
Oct 9th, 2024
Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

PHILADELPHIA - October 10, 2024 - Clario, a leading provider of endpoint data solutions to the clinical trials industry, is excited to announce a strategic partnership with PathAI, a leader in AI-powered digital pathology solutions aimed at improving diagnostic accuracy and efficiency.

INACTIVE